StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1156
This month
14
This week
6
This year
109
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 08 - 25
4
2021 - 08 - 19
4
2021 - 08 - 05
6
2021 - 05 - 10
4
2021 - 04 - 13
3
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 18
4
Sector
Commercial services
12
Communications
8
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
19
Finance
6
Health care and social assistance
1
Health services
17
Health technology
1156
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
16
Producer manufacturing
21
Professional, scientific, and technical services
20
Retail trade
3
Technology services
17
Tags
Agreement
9
Alzheimer's
10
America
67
Antibody
12
Application
10
Approval
17
Biosimilar
36
Breast
13
Cancer
98
Chmp
10
Device
11
Diabetes
16
Diagnostics
19
Disease
73
Drug
107
Earnings
21
Europe
15
Expansion
11
Expected
35
Eye
16
Fda
25
Financial
24
Financial results
12
Global
229
Growing
46
Growth
252
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
16
Market
598
N/a
1051
Novartis
133
Patent
12
People
19
Pharma
15
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
195
Research
125
Respiratory
14
Results
47
Risk
11
Sales
10
Sclerosis
13
Set
15
Study
17
T-cell
11
Technology
14
Therapeutics
113
Therapy
80
Treatment
123
Trial
19
Update
10
Vaccine
15
Year
12
Entities
3m company
12
Abbott laboratories
116
Abbvie inc.
237
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
14
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
198
Autolus therapeutics plc
7
Bausch health companies inc.
68
Baxter international inc.
47
Becton, dickinson and company
18
Beigene, ltd.
7
Biogen inc.
54
Biomarin pharmaceutical inc.
7
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
15
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
99
Csl ltd
9
Danaher corporation
11
Eli lilly and company
136
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
300
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
227
Koninklijke philips n.v.
18
Mallinckrodt plc
17
Medtronic plc
35
Morphosys ag
15
Novartis ag
1156
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Pfizer, inc.
84
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
329
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
AAPL
1198
ABB
1204
ABBV
608
ABLZF
1166
ABT
1074
ACAQ
522
AMGN
742
AMSIY
465
AMSYF
465
ARCXF
465
ARVL
4294
AVGO
593
AZN
665
BNPQF
1764
BNPQY
1764
CRCW
473
CSCO
897
DNZOF
504
DNZOY
504
ERIC
1612
EXTR
581
FNCTF
7191
FRBA
598
GE
508
GILD
500
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
811
HON
1026
IFNNF
531
IFNNY
509
INTC
955
JNJ
2072
LLY
1088
LTUM
971
MAR
474
MDT
731
MS
1788
MSFT
1201
MT
473
NIPNF
533
NOK
859
NOKBF
975
NVDA
517
NVS
1156
NVSEF
1031
ORCL
787
PCRFF
650
PCRFY
650
PHG
476
PPRUF
1128
PPRUY
1129
SAP
1379
SAPGF
1231
SNY
4539
SNYNF
3597
TEVJF
631
TMO
706
VSAC
534
Exchanges
Amex
7
Nasdaq
1156
Nyse
1241
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
6
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 08 - 25
4
2021 - 08 - 19
4
2021 - 08 - 05
6
2021 - 05 - 10
4
2021 - 03 - 18
4
Crawled Time
00:00
43
00:20
10
01:00
47
02:00
25
03:00
34
04:00
22
04:20
8
05:00
23
06:00
60
07:00
35
08:00
33
08:20
4
08:23
1
09:00
43
10:00
32
11:00
50
11:01
1
12:00
78
12:15
4
12:20
14
12:30
8
13:00
31
13:14
1
13:15
4
13:20
8
13:30
5
14:00
43
14:15
2
14:20
10
14:30
7
14:49
1
15:00
51
15:15
4
15:20
16
15:30
16
16:00
55
16:20
3
17:00
57
18:00
53
19:00
44
20:00
41
20:20
3
21:00
31
22:00
51
23:00
43
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
spacfeed.com
1
www.biospace.com
105
www.globenewswire.com
190
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
852
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVS
exchanges :
Nasdaq
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-2.24%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.66%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-12.08%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.66%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-0.62%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.17%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
-3.34%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-1.85%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
|
-0.51%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.17%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-1.99%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
$5.22
-10.92%
-12.26%
9.1M
|
Health Technology
|
-32.56%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.19%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.17%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-1.85%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-1.42%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.93%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.22%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
-3.15%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-0.26%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.29%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.17%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$34.78
1.43%
1.41%
940K
|
Health Technology
|
-3.9%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.49%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
-0.08%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-9.51%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.16%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-9.26%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-4.01%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-7.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.37%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.59%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-4.92%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.24%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-4.66%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.49%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.66%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-16.52%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-0.9%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.33%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.63%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.42
-0.41%
29K
|
n/a
|
-4.6%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-1.43%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.05%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
0.3%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$19.98
2.78%
2.7%
140K
|
n/a
|
-11.05%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.1%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.1%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.59
-4.14%
-4.32%
10K
|
Health Technology
|
32.81%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.55
1.38%
-0.25%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.59%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.25%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.54%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.67%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-8.11%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.07%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.11%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.59%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.54%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-8.11%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.73%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.27%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.88%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.42%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.07%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.79
0.0%
570K
|
|
-13.11%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.59%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.67%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
57
58
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.